Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujisaka

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
Journal of Medical Virology|June 27, 2015
Shifting hepatitis B virus genotypes of acute hepatitis B patients in northeast JapanJun Inoue, Yasuteru Kondo, Teruyuki Umetsu, et al.
International Journal of Molecular Sciences|February 25, 2023
Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in MiceKaichi Kasai, Naoya Igarashi, Yuki Tada, et al.
JTO Clinical and Research Reports|October 17, 2024
The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study)Kageaki Watanabe, Yukio Hosomi, Katsuhiko Naoki, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2026
Acute Exacerbation of Pre-existing Cancer-Related Pain: An Atypical Presentation of an Amivantamab-Induced Infusion-Related ReactionRyutaro Yamaguchi, Yosuke Tamura, Yuki Asai, et al.
The Journal of Clinical Investigation|October 4, 2017
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signalingSamir Softic, Manoj K Gupta, Guo-Xiao Wang, et al.
The Journal of Clinical Investigation|March 2, 2018
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signalingSamir Softic, Manoj K Gupta, Guo-Xiao Wang, et al.
Diabetes Research and Clinical Practice|January 24, 2007
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patientsIsao Usui, Shiho Fujisaka, Katsuya Yamazaki, et al.
Plos One|March 24, 2021
Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissueTakahide Kuwano, Hironori Izumi, Muhammad Rahil Aslam, et al.
Diabetology International|January 4, 2019
Deletion of SIRT1 in myeloid cells impairs glucose metabolism with enhancing inflammatory response to adipose tissue hypoxiaAkiko Takikawa, Isao Usui, Shiho Fujisaka, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 3, 2009
Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG miceYu Yamazaki, Isao Usui, Yukiko Kanatani, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Journal of Medical Virology|June 27, 2015
Shifting hepatitis B virus genotypes of acute hepatitis B patients in northeast JapanJun Inoue, Yasuteru Kondo, Teruyuki Umetsu, et al.
International Journal of Molecular Sciences|February 25, 2023
Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in MiceKaichi Kasai, Naoya Igarashi, Yuki Tada, et al.
JTO Clinical and Research Reports|October 17, 2024
The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study)Kageaki Watanabe, Yukio Hosomi, Katsuhiko Naoki, et al.
Internal Medicine (Tokyo, Japan)|July 5, 2026
Acute Exacerbation of Pre-existing Cancer-Related Pain: An Atypical Presentation of an Amivantamab-Induced Infusion-Related ReactionRyutaro Yamaguchi, Yosuke Tamura, Yuki Asai, et al.
The Journal of Clinical Investigation|October 4, 2017
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signalingSamir Softic, Manoj K Gupta, Guo-Xiao Wang, et al.
The Journal of Clinical Investigation|March 2, 2018
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signalingSamir Softic, Manoj K Gupta, Guo-Xiao Wang, et al.
Diabetes Research and Clinical Practice|January 24, 2007
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patientsIsao Usui, Shiho Fujisaka, Katsuya Yamazaki, et al.
Plos One|March 24, 2021
Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissueTakahide Kuwano, Hironori Izumi, Muhammad Rahil Aslam, et al.
Diabetology International|January 4, 2019
Deletion of SIRT1 in myeloid cells impairs glucose metabolism with enhancing inflammatory response to adipose tissue hypoxiaAkiko Takikawa, Isao Usui, Shiho Fujisaka, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 3, 2009
Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG miceYu Yamazaki, Isao Usui, Yukiko Kanatani, et al.
Pageof 26